KING OF PRUSSIA, PA — SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., has announced a major advancement in oncology with the discovery of PVTX-405, a potent IKZF2 molecular glue ...
NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- Proteovant Therapeutics, a Roivant Sciences (Nasdaq: ROIV) company leveraging the process of protein degradation to discover and develop transformative ...
KING OF PRUSSIA, Pa., May 1, 2025 /PRNewswire/ -- SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., a global biotech focused on the research, development, and commercialization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results